Genetically Engineered T-Cells Force Leukemia into Remission

A pretty amazing story indeed……13 people with a form of cancer called multiple myeloma were treated with genetically engineered T-Cells and all 13 are now in remission or close to it.  “The fact we got a response in all 13, you can’t get better than that,” says James Noble, CEO of Adaptimmune in Abingdon, UK, which developed the treatment.

The T-Cells can better recognise proteins called NY-ESO-1 and LAGE-1, these are found on myeloma cells only.  All 13 showed a boost in their white blood cell count.

We all probably know someone that has been taken b/c of cancer or is currently struggling with it.  It seems as though science has really made major strides in battling it, and we hope to hear more good news from this study after they’ve gone through additional trials.

Read more over at NewScientist.com

You may also like

Legislative panel approves medical malpractice bill
Read more
Urgent-care centers: Illinois numbers grow as time-pressed families seek low-cost option to ERs
Read more
Global Center for Medical Innovation launches
Read more

Recent Posts

Connecticut Supreme Court Narrows Scope of Physicians’ Immunity from Civil Liability During COVID

Rate of ‘Serious Discipline’ of Physicians by State Medical Boards Drops from Previous Benchmark

New York Lawmakers Again Vote to Update Wrongful Death Statute in Way Doctors Say Would Increase Damages, Harm Safety Net Care

Popular Posts

PIAA 2017: Current Trends & Future Concerns

Arizona Court Decisions Affirm Two Medical Professional Liability Reform Laws

2022 Medical Malpractice Insurance Rates: What the data tells us

Start Your Custom Quote Process™

Request a free quote